Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.
Andrade AF, Borges KS, Suazo VK, Geron L, Corrêa CA, Castro-Gamero AM, de Vasconcelos EJ, de Oliveira RS, Neder L, Yunes JA, Dos Santos Aguiar S, Scrideli CA, Tone LG. Andrade AF, et al. Invest New Drugs. 2017 Feb;35(1):26-36. doi: 10.1007/s10637-016-0401-4. Epub 2016 Oct 26. Invest New Drugs. 2017. PMID: 27785591
Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.
Andrade AF, Borges KS, Suazo VK, Geron L, Corrêa CA, Castro-Gamero AM, de Vasconcelos EJ, de Oliveira RS, Neder L, Yunes JA, Aguiar SD, Scrideli CA, Tone LG. Andrade AF, et al. Invest New Drugs. 2017 Feb;35(1):124. doi: 10.1007/s10637-016-0412-1. Invest New Drugs. 2017. PMID: 27900530 No abstract available.
Identification of ITPR1 as a Hub Gene of Group 3 Medulloblastoma and Coregulated Genes with Potential Prognostic Values.
das Chagas PF, de Sousa GR, Veronez LC, Martins-da-Silva A, Corrêa CAP, Cruzeiro GAV, Nagano LFP, Queiroz RGP, Marie SKN, Brandalise SR, Scrideli CA, Tone LG, Valera ET. das Chagas PF, et al. Among authors: correa cap. J Mol Neurosci. 2022 Mar;72(3):633-641. doi: 10.1007/s12031-021-01942-3. Epub 2021 Nov 25. J Mol Neurosci. 2022. PMID: 34822110
MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors.
Veronez LC, Fedatto PF, Correa CAP, Lira RCP, Baroni M, da Silva KR, Santos P, Antonio DSM, Queiroz RPS, Antonini SRR, Tucci S Jr, Neder L, Yunes JA, Brandalise SR, Panepucci RA, Tone LG, Scrideli CA. Veronez LC, et al. Among authors: correa cap. Pediatr Blood Cancer. 2022 Jul;69(7):e29553. doi: 10.1002/pbc.29553. Epub 2021 Dec 31. Pediatr Blood Cancer. 2022. PMID: 34971073
Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.
Martins-da-Silva A, Baroni M, Salomão KB, das Chagas PF, Bonfim-Silva R, Geron L, Cruzeiro GAV, da Silva WA Jr, Corrêa CAP, Carlotti CG Jr, de Paula Queiroz RG, Marie SKN, Brandalise SR, Yunes JA, Scrideli CA, Valera ET, Tone LG. Martins-da-Silva A, et al. Among authors: correa cap. Cell Mol Neurobiol. 2023 Mar;43(2):813-826. doi: 10.1007/s10571-022-01217-4. Epub 2022 Apr 2. Cell Mol Neurobiol. 2023. PMID: 35366170
MicroRNA-149-3p expression correlates with outcomes of adrenocortical tumor patients and affects proliferation and cell cycle progression of H295A adrenocortical cancer cell line.
da Silva KR, Veronez LC, Correa CAP, Lira RCP, Baroni M, de Paula Silva Queiroz R, Antonini SRR, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. da Silva KR, et al. Among authors: correa cap. Hum Cell. 2022 Nov;35(6):1952-1960. doi: 10.1007/s13577-022-00778-2. Epub 2022 Sep 2. Hum Cell. 2022. PMID: 36053456
Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells.
Chagas PS, Veronez LC, de Sousa GR, Cruzeiro GAV, Corrêa CAP, Saggioro FP, de Paula Queiroz RG, Marie SKN, Brandalise SR, Cardinalli IA, Yunes JA, Júnior CGC, Machado HR, Santos MV, Scrideli CA, Tone LG, Valera ET. Chagas PS, et al. Among authors: correa cap. Hum Cell. 2023 Nov;36(6):2129-2139. doi: 10.1007/s13577-023-00954-y. Epub 2023 Jul 17. Hum Cell. 2023. PMID: 37460706
Low PRKAB2 Expression Is Associated with Poor Outcomes in Pediatric Adrenocortical Tumors, and Treatment with Rottlerin Increases the PRKAB2 Level and Inhibits Tumorigenic Aspects in the NCI-H295R Adrenocortical Cancer Cell Line.
Xavier AET, Veronez LC, Nagano LFP, Correa CAP, Baroni M, Ramos MS, Queiroz RGP, Fernandes Molina CA, Yunes JA, Brandalise SR, Antonini SAR, Tone LG, Valera ET, Scrideli CA. Xavier AET, et al. Among authors: correa cap. Cancers (Basel). 2024 Mar 8;16(6):1094. doi: 10.3390/cancers16061094. Cancers (Basel). 2024. PMID: 38539429 Free PMC article.
Analysis of miR-483-3p and miR-630 expression profile in pediatric adrenocortical tumors and the effect of their modulation on adrenal tumorigenesis in vitro.
Corrêa CAP, Andrade AF, Veronez LC, da Silva KR, Baroni M, Suazo VK, de Paula Gomes Queiroz R, Lira RCP, Chagas PS, Brandalise SR, Yunes JA, Molina CAF, Antonini SRR, Valera ET, Tone LG, Scrideli CA. Corrêa CAP, et al. Mol Cell Endocrinol. 2024 Dec 1;594:112371. doi: 10.1016/j.mce.2024.112371. Epub 2024 Sep 14. Mol Cell Endocrinol. 2024. PMID: 39278396
14 results